Related Experiment Video
Updated: May 15, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
Chylous ascites after hepatopancreatobiliary surgery
S Kuboki1, H Shimizu, H Yoshidome
1Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-0856, Japan.
Postoperative chylous ascites is a rare complication after hepatopancreatobiliary (HPB) surgery, particularly pancreatic resections. Octreotide treatment combined with total parenteral nutrition is recommended for managing this condition.
Area of Science:
- Gastroenterology and Hepatology
- Surgical Oncology
- Abdominal Surgery
Background:
- Postoperative chylous ascites is an uncommon complication of abdominal surgery.
- It can lead to malnutrition, immunodeficiency, and increased mortality.
- Large-scale studies on chylous ascites in hepatopancreatobiliary (HPB) surgery are lacking.
Purpose of the Study:
- To determine the incidence of postoperative chylous ascites following HPB surgery.
- To identify risk factors associated with chylous ascites, especially after pancreatic resection.
- To evaluate the clinical efficacy of octreotide in managing chylous ascites.
Main Methods:
- Retrospective review of consecutive patients undergoing HPB surgery (2000-2011).
- Definition of chyle leak: ≥100 ml/day milky peritoneal fluid with triglycerides ≥110 mg/dl.
- Multivariable analysis to identify risk factors and assess octreotide efficacy.
Main Results:
- 21 out of 2002 patients (1.0%) developed chylous ascites.
- Higher incidence in pancreatic resections (pancreaticoduodenectomy 3.3%, distal pancreatectomy 3.8%).
- Independent risk factors: para-aortic manipulation, retroperitoneal invasion, early enteral feeding. Octreotide reduced drainage output (P=0.002).
Conclusions:
- Chylous ascites is a rare but significant complication of HPB surgery, more frequent after pancreatic resection.
- Para-aortic manipulation, retroperitoneal invasion, and early enteral feeding are key risk factors.
- Octreotide combined with total parenteral nutrition is the recommended treatment approach.
Related Concept Videos
Cholecystitis
Acute Pancreatitis II: Clinical Manifestations and Management
Ascites
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction